Chromocell Therapeutics Corp
AMEX:CHRO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Chromocell Therapeutics Corp
AMEX:CHRO
|
US |
Shareholder Yield
Current shareholder yield for CHRO is .
Peers Comparison
Shareholder Yield
Price Appreciation
CHRO Price
Chromocell Therapeutics Corp
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -89% |
| Market Capitalization | 3.8m USD |
| Shares Outstanding | 169 372 |
| Percentage of Shares Shorted | 1.3% |
CHRO Return Decomposition
Main factors of price return
Stock Splits
CHRO's latest stock split occurred on Jul 2, 2025
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, CHRO traded at 1.35 per share. Afterward, the share price was about 16.5.
The adjusted shares began trading on Jul 2, 2025. This was the only stock split in CHRO's history.